CapsoVision

CVNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$332.206 M

$6.25 -8.83%

Close of 6 Nov 2026

As of 6 Nov 2026, CapsoVision (CV) has a market capitalization of $332.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$13.6M

#3071 by revenue

Earnings

-$25.3M

Loss-making

Shares outstanding

50,046,913

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →

#7CeribellCBLL$1.01B
#8InModeINMD$769.4M
#9CapsoVisionCV$332.2M
#10ElectromedELMD$221.4M
#11Edap TmsFOCL$192.5M

What if CapsoVision were worth as much as…

Open the what-if tool →

Gold $28.2T

$530,812.29

Per share 84,998× higher

Bitcoin $1.53T

$28,721.33

Per share 4,599× higher

Apple $5.02T

$94,289.44

Per share 15,098× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for CapsoVision are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.